Literature DB >> 20107099

Circulation of mumps virus genotypes in Spain from 1996 to 2007.

J E Echevarría1, A Castellanos, J C Sanz, C Pérez, G Palacios, M V Martínez de Aragón, I Peña Rey, M Mosquera, F de Ory, E Royuela.   

Abstract

Although the WHO recommends the use of genotyping as a tool for epidemiological surveillance for mumps, limited data on mumps virus (MV) genotype circulation that may be used to trace the patterns of virus spread are available. We describe the first complete series of data from Spain. The small hydrophobic region was sequenced from 237 MV-positive samples from several regions of Spain collected between 1996 and 2007. Six different genotypes were identified: A, C, D (D1), G (G1, G2), H (H1, H2), and J. Genotype H1 was predominant during the epidemic that occurred from 1999 to 2003 but was replaced by genotype G1 as the dominant genotype in the epidemic that occurred from 2005 to 2007. The same genotype G1 strain caused concomitant outbreaks in different parts of the world (the United States, Canada, and the United Kingdom). The remaining genotypes (genotypes A, C, D, and J) appeared in sporadic cases or small limited outbreaks. This pattern of circulation seems to reflect continuous viral circulation at the national level, despite the high rates of vaccine coverage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107099      PMCID: PMC2849537          DOI: 10.1128/JCM.02386-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Proposed criteria for classification of new genotypes of mumps virus.

Authors:  Bo Johansson; Tesfaldet Tecle; Claes Orvell
Journal:  Scand J Infect Dis       Date:  2002

2.  Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain.

Authors:  M Montes; G Cilla; J Artieda; D Vicente; M Basterretxea
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

3.  Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus.

Authors:  T Tecle; B Johansson; A Jejcic; M Forsgren; C Orvell
Journal:  J Gen Virol       Date:  1998-12       Impact factor: 3.891

4.  Genotypic characterization of mumps virus isolated in Russia (Siberia)

Authors:  A Heider; G Ignatyev; E Gerike; E Schreier
Journal:  Res Virol       Date:  1997 Nov-Dec

5.  Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.

Authors:  Juan Carlos Sanz-Moreno; Aurora Limia-Sánchez; Luis García-Comas; M Mar Mosquera-Gutiérrez; Juan Emilio Echevarria-Mayo; Ana Castellanos-Nadal; Fernando de Ory-Manchón
Journal:  Vaccine       Date:  2005-09-30       Impact factor: 3.641

6.  Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases.

Authors:  G P Poggio; C Rodriguez; D Cisterna; M C Freire; J Cello
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  New genotype of measles virus and update on global distribution of measles genotypes.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-10-07

8.  Screening of active lyssavirus infection in wild bat populations by viral RNA detection on oropharyngeal swabs.

Authors:  J E Echevarría; A Avellón; J Juste; M Vera; C Ibáñez
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

9.  Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating.

Authors:  M Takahashi; T Nakayama; Y Kashiwagi; T Takami; S Sonoda; T Yamanaka; H Ochiai; T Ihara; T Tajima
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

10.  Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.

Authors:  Alena V Atrasheuskaya; Elena M Blatun; Michail V Kulak; Alina Atrasheuskaya; Igor A Karpov; Steven Rubin; George M Ignatyev
Journal:  Vaccine       Date:  2007-04-25       Impact factor: 3.641

View more
  7 in total

1.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  [Study of a population-wide epidemic outbreak of mumps virus G1 in Jerez de la Frontera (Spain)].

Authors:  Pascasio Peña González; José Almenara Barrios; Juan Carlos Morales Serna
Journal:  Aten Primaria       Date:  2011-10-21       Impact factor: 1.137

4.  Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

Authors:  R Allwinn; B Zeidler; K Steinhagen; E Rohwäder; S Wicker; H F Rabenau; H W Doerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 3.267

5.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

6.  Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain.

Authors:  Irene Barrabeig; Andrés Antón; Núria Torner; Tomàs Pumarola; Josep Costa; Àngela Domínguez
Journal:  BMC Infect Dis       Date:  2019-11-09       Impact factor: 3.090

7.  Genomic non-coding regions reveal hidden patterns of mumps virus circulation in Spain, 2005 to 2015.

Authors:  Ana M Gavilán; Aurora Fernández-García; Angel Rueda; Ana Castellanos; Josefa Masa-Calles; Noemí López-Perea; María V Torres de Mier; Fernando de Ory; Juan E Echevarría
Journal:  Euro Surveill       Date:  2018-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.